InspireMD to Announce Second Quarter 2025 Financial Results
InspireMD (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system, will release its Q2 2025 financial results on Tuesday, August 5, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss financial results and recent highlights.
Investors can access the earnings call by dialing 1-800-579-2543 (domestic) or 1-785-424-1789 (international). A webcast will be available on InspireMD's website, and a replay will be archived for later viewing.
InspireMD (Nasdaq: NSPR), sviluppatore del sistema di stent carotideo CGuard® Prime, annuncerà i risultati finanziari del secondo trimestre 2025 martedì 5 agosto 2025. La società terrà una conference call e una webcast alle 8:30 del mattino, ora della costa orientale per discutere i risultati finanziari e gli ultimi aggiornamenti.
Gli investitori potranno partecipare alla chiamata componendo il numero 1-800-579-2543 (nazionale) o 1-785-424-1789 (internazionale). La webcast sarà disponibile sul sito web di InspireMD e la registrazione sarà archiviata per la visione successiva.
InspireMD (Nasdaq: NSPR), desarrollador del sistema de stent carotídeo CGuard® Prime, publicará sus resultados financieros del segundo trimestre de 2025 el martes 5 de agosto de 2025. La compañía realizará una llamada conferencia y una transmisión en vivo a las 8:30 a.m., hora del Este para discutir los resultados financieros y las novedades recientes.
Los inversores podrán acceder a la llamada de resultados marcando el 1-800-579-2543 (nacional) o el 1-785-424-1789 (internacional). La transmisión en vivo estará disponible en el sitio web de InspireMD y se archivará una repetición para su visualización posterior.
InspireMD (나스닥: NSPR)는 CGuard® Prime 경동맥 스텐트 시스템 개발업체로서, 2025년 8월 5일 화요일 2분기 2025년 재무실적을 발표할 예정입니다. 회사는 동부 표준시 오전 8시 30분에 재무실적 및 최근 주요 사항을 논의하기 위한 컨퍼런스 콜 및 웹캐스트를 진행합니다.
투자자들은 국내 전화번호 1-800-579-2543 또는 국제 전화번호 1-785-424-1789로 전화하여 실적 발표 통화에 참여할 수 있습니다. 웹캐스트는 InspireMD 웹사이트에서 제공되며, 다시보기용 아카이브도 마련됩니다.
InspireMD (Nasdaq : NSPR), développeur du système de stent carotidien CGuard® Prime, publiera ses résultats financiers du deuxième trimestre 2025 le mardi 5 août 2025. La société organisera une conférence téléphonique et une webdiffusion à 8h30, heure de l'Est pour discuter des résultats financiers et des faits marquants récents.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le 1-800-579-2543 (numéro national) ou le 1-785-424-1789 (numéro international). Une webdiffusion sera disponible sur le site web d'InspireMD, et un replay sera archivé pour une consultation ultérieure.
InspireMD (Nasdaq: NSPR), Entwickler des CGuard® Prime Carotis-Stentsystems, wird seine Finanzergebnisse für das zweite Quartal 2025 am Dienstag, den 5. August 2025 veröffentlichen. Das Unternehmen veranstaltet um 8:30 Uhr Eastern Time eine Telefonkonferenz und ein Webcast, um die Finanzergebnisse und aktuelle Highlights zu besprechen.
Investoren können die Gewinnkonferenz unter der Nummer 1-800-579-2543 (national) oder 1-785-424-1789 (international) erreichen. Das Webcast wird auf der Website von InspireMD verfügbar sein, und eine Aufzeichnung wird für eine spätere Ansicht archiviert.
- None.
- None.
MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD’s website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1723041&tp_key=b02c396fff
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contact:
Webb Campbell
Gilmartin Group LLC
Webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When will InspireMD (NSPR) report Q2 2025 earnings?
How can I listen to InspireMD's Q2 2025 earnings call?
What does InspireMD (NSPR) manufacture?
Will there be a replay of InspireMD's Q2 2025 earnings call?
